The Cure Council

Research supported and driven by the countdown to a cure initiative is guided by a group of eminent scientists who make up the Cure Council.

DAVID BALTIMORE, PH.D.

DAVID BALTIMORE, PH.D.

Professor of Biology, California Institute of Technology
Won the Nobel Prize in Medicine in 1975 at the age of 37—one of the youngest Nobelists of all time.

FRANÇOISE BARRÉ-SINOUSSI, PH.D.

FRANÇOISE BARRÉ-SINOUSSI, PH.D.

Director of the Regulation of Retroviral Infections Division, Pasteur Institute, Paris
Won the Nobel Prize in Medicine in 2008, with Dr. Luc Montagnier, for their discovery of HIV.

MYRON COHEN, M.D.

MYRON (MIKE) COHEN, M.D.

J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Public Health University of North Carolina, Chapel Hill
The HIV Prevention Trials Network 052 study (HPTN 052), led by Dr. Cohen, was named the 2011 Breakthrough of the Year by the journal Science. The study demonstrated that treating HIV-positive people early can lead to a 96% reduction in HIV transmission to their sex partners.

BEATRICE HAHN, M.D.

BEATRICE HAHN, M.D.

Professor of Medicine, Perelman School of Medicine, University of Pennsylvania
Recognized for deciphering the primate origins of human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2). Named by Discover magazine as one of “The 50 Most Important Women in Science” in 2002.

RICHARD JEFFERYS

RICHARD JEFFERYS

Basic Science, Vaccines, and Cure Project Coordinator at Treatment Action Group (TAG)
A highly respected voice in AIDS research, Richard Jefferys has more than 20 years experience in the field of HIV treatment access, clinical trials, and vaccine and cure research. Since joining the Treatment Action Group in 2001, he has worked for TAG’s Michael Palm Basic Science, Vaccines, and Cure Project. He also writes on the pathogenesis and immunology of HIV infection for a range of publications.

CARL JUNE, M.D.

CARL JUNE, M.D.

Professor in Immunology, Perelman School of Medicine, University of Pennsylvani
In September 2011 The New York Times described Dr. June’s work as “a turning point in the long struggle to develop effective gene therapies against cancer.”


Explore more about Countdown to a Cure